Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -33.27% is 23% above its 5-year average of -43.34%, near the high end of its 5-year range (-67.67%–-27.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.09% below its 12-month average of -31.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -33.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-33.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-31.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-45.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-43.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.09%
CURRENT VS 3Y AVG
+27.14%
CURRENT VS 5Y AVG
+23.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+6.67%
vs the sector median at left
Outset Medical, Inc.
Market Cap
$76.74M
Return on Invested Capital (ROIC)
-33.27%
TTM Avg
-31.07%
3Y Avg
-45.66%
5Y Avg
-43.34%
Market Cap
$77.54M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.95M
Return on Invested Capital (ROIC)
-1.02%
TTM Avg
-7.84%
3Y Avg
-8.62%
5Y Avg
-7.82%
Market Cap
$78.07M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$78.29M
Return on Invested Capital (ROIC)
-59.79%
TTM Avg
-61.79%
3Y Avg
-56.24%
5Y Avg
-67.61%
Market Cap
$75.18M
Return on Invested Capital (ROIC)
-48.39%
TTM Avg
-44.64%
3Y Avg
-40.56%
5Y Avg
-32.79%
Market Cap
$78.59M
Return on Invested Capital (ROIC)
-11.48%
TTM Avg
-56.27%
3Y Avg
-1130.61%
5Y Avg
-797.97%
Market Cap
$79.03M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
Market Cap
$79.61M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | $76.74M | -33.27% | -31.07% | -45.66% | -43.34% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | -1.02% | -7.84% | -8.62% | -7.82% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -836.58% | -213.85% | -158.30% | -121.35% |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -59.79% | -61.79% | -56.24% | -67.61% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -48.39% | -44.64% | -40.56% | -32.79% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -11.48% | -56.27% | -1130.61% | -797.97% |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -88.72% | -42.77% | -39.33% | -39.33% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | -88.28% | -61.59% | -48.92% | -67.61% |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | -62.98% | -85.67% | -71.66% | -59.37% |
ROIC
-33.3%
ROE
-77.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -33.27% |
| 2026-03-31 | -31.73% |
| 2025-12-31 | -29.40% |
| 2025-09-30 | -29.58% |
| 2025-06-30 | -31.35% |
| 2025-03-31 | -34.78% |
| 2024-12-31 | -49.20% |
| 2024-09-30 | -51.45% |
| 2024-06-30 | -55.51% |
| 2024-03-31 | -55.21% |
| 2023-12-31 | -65.68% |
| 2023-09-30 | -67.67% |
| 2023-06-30 | -58.74% |
| 2023-03-31 | -52.77% |
| 2022-12-31 | -46.25% |
| 2022-09-30 | -51.25% |
| 2022-06-30 | -43.40% |
| 2022-03-31 | -35.87% |
| 2021-12-31 | -31.70% |
| 2021-09-30 | -27.12% |
| 2021-06-30 | -28.11% |
| 2021-03-31 | -36.79% |
| 2020-12-31 | -32.00% |
| 2020-09-30 | -26.57% |
| 2020-06-30 | -50.94% |
| 2020-03-31 | -41.63% |
| 2019-12-31 | -99.09% |
